查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
干眼症治疗市场规模、份额和趋势分析报告：按类型（蒸汽、房水缺乏）、按产品、按配方、按销售渠道、按分销渠道、按地区、按细分市场、2022 ～2030 年预测
市场调查报告书
商品编码
1122235

干眼症治疗市场规模、份额和趋势分析报告：按类型（蒸汽、房水缺乏）、按产品、按配方、按销售渠道、按分销渠道、按地区、按细分市场、2022 ～2030 年预测

Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type (Evaporative, Aqueous Deficient), By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

干眼症治疗市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球干眼症治疗市场规模预计将达到 74.3 亿美元，从 2022 年到 2030 年，复合年增长率为 4.31%。市场增长归因于屏幕使用量增加、老年人口增加和眼病患病率上升等因素。

屏幕设备的使用增加、计算机使用的迅速增加以及眨眼次数的减少正在促进蒸发性干眼症世界的发展。例如，根据 2021 Frontiers Journal，与大流行前相比，在 COVID-19 大流行期间，成年人的屏幕使用量增加了 60-80%。触摸屏幕可减少 66% 的眨眼次数，这会加速眼泪的蒸发，导致眼睛干涩。

由于处方药渗透率极低，OTC 药物在市场上占主导地位。例如，只有 10% 的被诊断患有干眼症的人接受过处方治疗，而 75% 的人从未接受过处方治疗。然而，被诊断患有干眼症的患者人数占所有眼科医生的 5-35%。

此外，Xiidra 和 Restasis 等现有产品存在需要数月或数週才能显示结果的问题。眼科医生还表示，这些产品存在耐受性问题，失败率高达 50%。这表明市场需求未得到满足，预计将为计划在未来几年推出的管道产品创造有利可图的机会。此外，与药品相关的法规进一步阻碍了整个市场的增长。例如，2020 年，在监管机构对 Xiidra 的使用提出重大反对后，Novartis不得不主动撤回其在欧洲的使用。

主要参与者的创新和战略举措正在推动市场。新品发布是玩家常用的策略。例如，2021 年 10 月，Oyster Point Pharma 的 Tyrvaya（伐尼克兰溶液）鼻喷雾剂被 FDA 批准为替代治疗方法。

干眼症治疗市场报告亮点

按类型划分，由于患病率增加和筛查时间增加，蒸发过强型干眼症在 2021 年占最大份额

按剂型来看，眼药水在 2021 年的销售额中占最大份额，因为它们的可用性和对眼药水的偏好日益增加。

按药物划分，作为治疗干眼症的处方药采用率较高的 Restasis 将在 2021 年占据最大的市场份额

从销售渠道来看，越来越多的消费者因为便利性而选择在线药店，预计在线药店将在预测期内以最快的速度增长。

2021年北美的市场规模将非常大，因为它的高患病率、高认知度和高治疗率。

目录

第一章 调查方法和范围

  • 市场细分
    • 段范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 第一次调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法一：商品流动方法
      • 方法 2：使用自下而上的方法进行国别市场估算
      • 方法 3：使用自上而下的方法进行国别市场估算
  • 全球市场：复合年增长率计算
  • 调查假设
  • 市场份额计算
  • 二级信息列表
  • 目的
  • 缩略语表

第二章执行摘要

  • 市场概况

3. 干眼症治疗市场——行业展望

  • 市场系列展望
    • 母市场谱系展望
    • 相关/子公司市场展望
  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力
      • 老年人口不断增长
      • 眼部相关疾病的患病率增加
      • 对干眼症的认识越来越高
      • 增加隐形眼镜的使用
    • 市场约束分析
      • 缺乏熟练的眼科医生
  • SWOT 分析，按因素（政治和法律、经济和技术）
  • 行业分析——波特五力
  • 监管场景
  • 重大交易和战略联盟
    • 新产品发布
    • 获得
    • 扩张
    • 合伙

4 干眼症治疗市场：竞争分析

  • 主要市场参与者的最新发展和影响分析
    • 安索夫矩阵`
  • 公司分类
    • 创新者
      • 市场差异化因素
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 主要客户
    • 2021 年主要参与者的市场份额分析
  • 上市公司
    • 竞争仪錶盘分析
  • 民营企业
    • 主要初创企业名单
  • 区域网络图
  • 主要区域/本地竞争对手

第 5 章干眼症治疗市场分析：Typescope，2018-2030 年（收入，百万美元）

  • 干眼症治疗市场：类型的变异分析
  • 蒸发过强型干眼症
  • 房水缺乏干眼症

第 6 章干眼症治疗市场分析：药物范围，2018-2030 年（收入，百万美元）

  • 干眼症治疗市场：药物变异分析
  • Restasis
  • Xiidra
  • Cequa
  • Eysuvis
  • Tyrvaya
  • 其他

第 7 章干眼症治疗市场分析：产品范围，2018-2030 年（收入，百万美元）

  • 干眼症治疗市场：产品变异分析
  • 环孢素
  • 外用皮质类固醇
  • 人工泪液
  • 泪管塞
    • 可拆卸的
    • 熔化
  • 口服欧米茄补充剂
  • 其他

8 干眼症治疗市场分析：剂型范围，2018-2030 年（收入，百万美元）

  • 干眼症治疗市场：配方变化分析
  • 凝胶
  • 眼药水
  • 胶囊/片剂
  • 眼药水
  • 软膏

第 9 章干眼症治疗市场分析：2018-2030 年分销渠道范围（收入，百万美元）

  • 干眼症治疗市场：市场波动分析
  • 处方
  • 场外交易

第 10 章干眼症治疗市场分析：分销渠道范围，2018-2030 年（收入，百万美元）

  • 干眼症治疗市场：分销渠道的变化分析
  • 医院药房
  • 网上药店
  • 零售药店

第 11 章干眼症治疗市场分析，区域范围，2018-2030，（收入，百万美元）

  • 2021 年和 2030 年按国家/地区分列的市场份额分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 意大利
      • 西班牙
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

12 干眼症治疗市场：公司概况

  • 公司简介
    • Novartis AG
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AbbVie, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Sun Pharmaceutical Industries Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Santen Pharmaceutical Co., Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AFT Pharmaceuticals
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Johnson & Johnson Services, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Otsuka Pharmaceutical Co., Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • OASIS Medical.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Oyster Point Pharma, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Bausch & Lomb
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-974-4

Dry Eye Syndrome Treatment Market Growth & Trends:

The global dry eye syndrome treatment market size is expected to reach USD 7.43 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.31% from 2022 to 2030. The growth of the market is attributed to factors such as the increasing use of screens, the rising geriatric population, and a heightened prevalence of eye diseases.

The heightened use of devices with a screen, surging use of computers, and a decreased number of blinks are subsequently leading to the growth of evaporative dry eye syndrome globally. For instance, as per Frontiers Journal in 2021, when compared to pre-pandemic years, the use of screens has increased by 60-80% in adults during the COVID-19 pandemic. The exposure to the screen leads to a 66% decreased blinking rate, thus escalating the evaporation of tears and leading to dry eye disease.

Over-the-counter (OTC) products predominate the marketplace due to the extremely low acceptance of prescription products. For instance, only 10% of the diagnosed population is on prescription therapies, while 75% of the population has never tried prescription therapy. However, the number of patients diagnosed with dry eye syndrome accounts for 5-35% of overall ophthalmologist visits.

Moreover, existing products such as Xiidra and Restasis take months or weeks to demonstrate effects. In addition, as per eye consultants, these products have tolerability issues and a failure rate of as high as 50%. This depicts an unmet need in the market and is anticipated to create a lucrative opportunity for pipeline products expected to launch in the upcoming years. Moreover, regulations associated with the drugs further hamper the growth of the overall market. For instance, in 2020, Novartis had to voluntarily withdraw the use of Xiidra in Europe after regulators raised major objections to its use of xiidra.

Innovations and strategic initiatives by key players are driving the market. New product launch is a common strategy being used by the players. For instance, in October 2021, Tyrvaya (varenicline solution) nasal spray by Oyster Point Pharma was approved by the FDA as an alternative treatment approach.

Dry Eye Syndrome Treatment Market Report Highlights:

  • By type, evaporative dry eye syndrome held the largest share in 2021 owing to the increasing prevalence of the condition and heightened screen time
  • Based on dosage form, eye drops held the largest revenue share in 2021 owing to easy availability as well as increased preference for eye drop administration of the product
  • By drug, Restasis held the largest market share in 2021 owing to its high adoption as a prescription drug for dry eye treatment
  • Based on distribution channel, online pharmacies are expected to grow at the fastest rate over the forecast period due to the increased consumer preference for online pharmacies owing to the convenience
  • North America dominated the market in 2021 due to the high prevalence of the disease, surging awareness, and enhanced treatment rate

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
      • 1.6.1.3 Approach 3: Country-wise market estimation using top-down approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 Market Share Calculations
  • 1.10 List of Secondary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
  • 1.12 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Dry Eye Syndrome Treatment Market - Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Growing geriatric population
      • 3.3.1.2 Increasing prevalence of eye-related diseases
      • 3.3.1.3 Growth in awareness of dry eye syndrome
      • 3.3.1.4 Increasing use of contact lenses
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Lack of skilled ophthalmologists
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's Five Forces
  • 3.6 Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships

Chapter 4 Dry Eye Syndrome Treatment Market: Competitive Analysis

  • 4.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 4.1.1 Ansoff matrix`
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Competitive dashboard analysis
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
  • 4.6 Regional Network Map
  • 4.7 Key Regional/Local Competitors

Chapter 5 Dry Eye Syndrome Treatment Market Analysis: Type Scope, 2018 - 2030 (Revenue, USD Million)

  • 5.1 Dry Eye Syndrome Treatment Market: Type Movement Analysis
  • 5.2 Evaporative Dry Eye Syndrome
    • 5.2.1 Evaporative dry eye syndrome market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3 Aqueous Deficient Dry Eye Syndrome
    • 5.3.1 Aqueous deficient dry eye syndrome market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Dry Eye Syndrome Treatment Market Analysis: Drug Scope, 2018 - 2030 (Revenue, USD Million)

  • 6.1 Dry Eye Syndrome Treatment Market: Drug Movement Analysis
  • 6.2 Restasis
    • 6.2.1 Restasis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Xiidra
    • 6.3.1 Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Cequa
    • 6.4.1 Cequa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5 Eysuvis
    • 6.5.1 Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6 Tyrvaya
    • 6.6.1 Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Dry Eye Syndrome Treatment Market Analysis: Product Scope, 2018 - 2030 (Revenue, USD Million)

  • 7.1 Dry Eye Syndrome Treatment Market: Product Movement Analysis
  • 7.2 Cyclosporine
    • 7.2.1 Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3 Topical Corticosteroids
    • 7.3.1 Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4 Artificial Tears
    • 7.4.1 Artificial Tears market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5 Punctal Plugs
    • 7.5.1 Punctal Plugs market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2 Removable
      • 7.5.2.1 Removable market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3 Dissolvable
      • 7.5.3.1 Dissolvable market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6 Oral Omega Supplements
    • 7.6.1 Oral Omega Supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7 Others
    • 7.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Dry Eye Syndrome Treatment Market Analysis: Dosage Form Scope, 2018 - 2030 (Revenue, USD Million)

  • 8.1 Dry Eye Syndrome Treatment Market: Dosage Form Movement Analysis
  • 8.2 Gels
    • 8.2.1 Gels market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Eye Solution
    • 8.3.1 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Capsules & Tablets
    • 8.4.1 Capsules & tablets market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5 Eye Drops
    • 8.5.1 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6 Ointments
    • 8.6.1 Ointments market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Dry Eye Syndrome Treatment Market Analysis: Sales Channel Scope, 2018 - 2030 (Revenue, USD Million)

  • 9.1 Dry Eye Syndrome Treatment Market: Sales Channel Movement Analysis
  • 9.2 Prescription
    • 9.2.1 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.3 OTC
    • 9.3.1 OTC market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Dry Eye Syndrome Treatment Market Analysis: Distribution Channel Scope, 2018 - 2030 (Revenue, USD Million)

  • 10.1 Dry Eye Syndrome Treatment Market: Distribution Channel Movement Analysis
  • 10.2 Hospital Pharmacies
    • 10.2.1 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.3 Online Pharmacies
    • 10.3.1 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 10.4 Retail Pharmacies
    • 10.4.1 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 11 Dry Eye Syndrome Treatment Market Analysis, Regional Scope, 2018 - 2030, (Revenue, USD Million)

  • 11.1 Market Share Analysis by Country, 2021 & 2030
    • 11.1.1 North America
      • 11.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.1.2 U.S.
      • 11.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.1.3 Canada
      • 11.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.2 Europe
      • 11.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.2 U.K.
      • 11.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.3 Germany
      • 11.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.4 France
      • 11.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.5 Italy
      • 11.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.2.6 Spain
      • 11.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.3 Asia Pacific
      • 11.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.2 Japan
      • 11.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.3 China
      • 11.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.4 India
      • 11.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.5 South Korea
      • 11.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.3.6 Australia
      • 11.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.4 Latin America
      • 11.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.4.2 Brazil
      • 11.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.4.3 Mexico
      • 11.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.4.4 Argentina
      • 11.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 11.1.5 Middle East and Africa
      • 11.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.5.2 South Africa
      • 11.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.5.3 Saudi Arabia
      • 11.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 11.1.5.4 UAE
      • 11.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 12 Dry Eye Syndrome Treatment Market: Company Profiling

  • 12.1 Company Profiles
    • 12.1.1 Novartis AG
      • 12.1.1.1 Company overview
      • 12.1.1.2 Financial performance
      • 12.1.1.3 Product benchmarking
      • 12.1.1.4 Strategic initiatives
    • 12.1.2 AbbVie, Inc.
      • 12.1.2.1 Company overview
      • 12.1.2.2 Financial performance
      • 12.1.2.3 Product benchmarking
      • 12.1.2.4 Strategic initiatives
    • 12.1.3 Sun Pharmaceutical Industries Ltd.
      • 12.1.3.1 Company overview
      • 12.1.3.2 Financial performance
      • 12.1.3.3 Product benchmarking
      • 12.1.3.4 Strategic initiatives
    • 12.1.4 Santen Pharmaceutical Co., Ltd.
      • 12.1.4.1 Company overview
      • 12.1.4.2 Financial performance
      • 12.1.4.3 Product benchmarking
      • 12.1.4.4 Strategic initiatives
    • 12.1.5 AFT Pharmaceuticals
      • 12.1.5.1 Company overview
      • 12.1.5.2 Financial performance
      • 12.1.5.3 Product benchmarking
      • 12.1.5.4 Strategic initiatives
    • 12.1.6 Johnson & Johnson Services, Inc.
      • 12.1.6.1 Company overview
      • 12.1.6.2 Financial performance
      • 12.1.6.3 Product benchmarking
      • 12.1.6.4 Strategic initiatives
    • 12.1.7 Otsuka Pharmaceutical Co., Ltd.
      • 12.1.7.1 Company overview
      • 12.1.7.2 Financial performance
      • 12.1.7.3 Product benchmarking
      • 12.1.7.4 Strategic initiatives
    • 12.1.8 OASIS Medical.
      • 12.1.8.1 Company overview
      • 12.1.8.2 Financial performance
      • 12.1.8.3 Product benchmarking
      • 12.1.8.4 Strategic initiatives
    • 12.1.9 Oyster Point Pharma, Inc.
      • 12.1.9.1 Company overview
      • 12.1.9.2 Financial performance
      • 12.1.9.3 Product benchmarking
      • 12.1.9.4 Strategic initiatives
    • 12.1.10 Bausch & Lomb
      • 12.1.10.1 Company overview
      • 12.1.10.2 Financial performance
      • 12.1.10.3 Product benchmarking
      • 12.1.10.4 Strategic initiatives

List of Tables

  • 1. List of Secondary Sources
  • 2. List of Abbreviations
  • 3. Incidence of Diseases
  • 4. Global Dry Eye Syndrome Treatment Market, By Region, 2018 - 2030 (USD Million)
  • 5. Global Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 6. Global Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 7. Global Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 8. Global Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 9. Global Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 10. Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 11. North America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 12. North America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 13. North America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 14. North America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 15. North America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 16. North America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 17. North America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 18. U.S. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 19. U.S. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 20. U.S. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 21. U.S. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 22. U.S. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 23. U.S. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 24. Canada Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 25. Canada Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 26. Canada Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 27. Canada Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 28. Canada Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 29. Canada Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 30. Europe Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 31. Europe Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 32. Europe Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 33. Europe Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 34. Europe Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 35. Europe Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 36. Germany Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 37. Germany Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 38. Germany Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 39. Germany Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 40. Germany Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 41. Germany Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 42. U.K. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 43. U.K. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 44. U.K. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 45. U.K. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 46. U.K. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 47. U.K. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 48. France Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 49. France Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 50. France Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 51. France Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 52. France Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 53. France Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 54. Italy Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 55. Italy Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 56. Italy Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 57. Italy Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 58. Italy Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 59. Italy Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 60. Spain Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 61. Spain Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 62. Spain Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 63. Spain Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 64. Spain Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 65. Spain Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 66. Asia Pacific Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 67. Asia Pacific Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 68. Asia Pacific Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 69. Asia Pacific Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 70. Asia Pacific Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 71. Asia Pacific Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 72. Asia Pacific Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 73. Japan Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 74. Japan Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 75. Japan Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 76. Japan Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 77. Japan Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 78. Japan Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 79. China Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 80. China Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 81. China Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 82. China Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 83. China Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 84. China Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 85. India Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 86. India Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 87. India Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 88. India Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 89. India Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 90. India Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 91. South Korea Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 92. South Korea Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 93. South Korea Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 94. South Korea Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 95. South Korea Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 96. South Korea Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 97. Australia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 98. Australia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 99. Australia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 100. Australia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 101. Australia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 102. Australia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 103. Latin America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 104. Latin America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 105. Latin America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 106. Latin America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 107. Latin America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 108. Latin America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 109. Latin America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 110. Brazil Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 111. Brazil Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 112. Brazil Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 113. Brazil Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 114. Brazil Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 115. Brazil Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 116. Mexico Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 117. Mexico Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 118. Mexico Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 119. Mexico Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 120. Mexico Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 121. Mexico Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 122. Argentina Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 123. Argentina Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 124. Argentina Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 125. Argentina Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 126. Argentina Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 127. Argentina Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 128. Middle East & Africa Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
  • 129. Middle East & Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 130. Middle East & Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 131. Middle East & Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 132. Middle East & Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 133. Middle East & Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 134. Middle East & Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 135. Saudi Arabia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 136. Saudi Arabia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 137. Saudi Arabia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 138. Saudi Arabia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 139. Saudi Arabia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 140. Saudi Arabia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 141. South Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 142. South Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 143. South Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 144. South Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 145. South Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 146. South Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • 147. UAE Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
  • 148. UAE Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
  • 149. UAE Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
  • 150. UAE Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • 151. UAE Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
  • 152. UAE Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • 1. Market Research Process
  • 2. Information Procurement
  • 3. Primary Research Pattern
  • 4. Market Research Approaches
  • 5. Value Chain-Based Sizing & Forecasting
  • 6. Market Formulation & Validation
  • 7. Dry Eye Syndrome Treatment Market Segmentation
  • 8. Market Driver Relevance Analysis (Current & Future Impact)
  • 9. Market Restraint Relevance Analysis (Current & Future Impact)
  • 10. Market Challenge Relevance Analysis (Current & Future Impact)
  • 11. Penetration & Growth Prospect Mapping
  • 12. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 13. Porter's Five Forces Analysis
  • 14. Market Penetration & Growth Prospect Mapping
  • 15. Dry eye syndrome treatment market: Type outlook and key takeaways
  • 16. Dry eye syndrome treatment market: Type movement analysis & market share 2021 & 2030
  • 17. Evaporative dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • 18. Aqueous dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • 19. Dry eye syndrome treatment market: Drug outlook and key takeaways
  • 20. Dry eye syndrome treatment market: Drug movement analysis & market share 2021 & 2030
  • 21. Restasis market estimates and forecast, 2018 - 2030 (USD Million)
  • 22. Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
  • 23. Cequa market estimates and forecast, 2018 - 2030 (USD Million)
  • 24. Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
  • 25. Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
  • 26. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 27. Dry eye syndrome treatment market: Product outlook and key takeaways
  • 28. Dry eye syndrome treatment market: Product movement analysis & market share 2021 & 2030
  • 29. Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
  • 30. Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • 31. Artificial tears market estimates and forecast, 2018 - 2030 (USD Million)
  • 32. Punctal plugs market estimates and forecast, 2018 - 2030 (USD Million)
  • 33. Oral omega supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • 34. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 35. Dry eye syndrome treatment market: Dosage form outlook and key takeaways
  • 36. Dry eye syndrome treatment market: Dosage form movement analysis & market share 2021 & 2030
  • 37. Gels market estimates and forecast, 2018 - 2030 (USD Million)
  • 38. Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • 39. Capsules and tablets market estimates and forecast, 2018 - 2030 (USD Million)
  • 40. Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • 41. Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • 42. Dry eye syndrome treatment market: Sales channel outlook and key takeaways
  • 43. Dry eye syndrome treatment market: Sales channel movement analysis & market share 2021 & 2030
  • 44. Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • 45. OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • 46. Dry eye syndrome treatment market: Distribution channel outlook and key takeaways
  • 47. Dry eye syndrome treatment market: Distribution channel movement analysis & market share 2021 & 2030
  • 48. Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 49. Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 50. Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 51. Regional Marketplace: Key Takeaways
  • 52. Regional Outlook, 2018 & 2030
  • 53. Regional Market Dashboard
  • 54. Regional Market Place: Key Takeaways
  • 55. North America, SWOT Analysis
  • 56. Europe, SWOT Analysis
  • 57. Asia Pacific, SWOT Analysis
  • 58. Latin America, SWOT Analysis
  • 59. MEA, SWOT Analysis
  • 60. North America
  • 61. North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 62. U.S.
  • 63. U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 64. Canada
  • 65. Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 66. Europe
  • 67. Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 68. U.K.
  • 69. U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 70. Germany
  • 71. Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 72. France
  • 73. France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 74. Italy
  • 75. Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 76. Spain
  • 77. Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 78. Asia Pacific
  • 79. Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 80. Japan
  • 81. Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 82. China
  • 83. China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 84. India
  • 85. India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 86. Australia
  • 87. Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 88. South Korea
  • 89. South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 90. Latin America
  • 91. Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 92. Brazil
  • 93. Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 94. Mexico
  • 95. Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 96. Argentina
  • 97. Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 98. MEA
  • 99. MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 100. South Africa
  • 101. South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 102. Saudi Arabia
  • 103. Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 104. UAE
  • 105. UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 106. Strategy Mapping